Clinical Trials List
2021-03-01 - 2028-03-31
Phase III
Not yet recruiting3
ICD-10B20
Human immunodeficiency virus [HIV] disease
ICD-9042
Human immunodeficiency virus（HIV）infection disease
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 蔡宏津 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Nan-Yao Lee Division of General Internal Medicine
- 薛伶珊 Division of General Internal Medicine
- 李佳雯 Division of General Internal Medicine
- 李明吉 Division of General Internal Medicine
- Po-Lin Chen Division of General Internal Medicine
- 羅景霳 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Tiffany Ting-Fang Shih Division of General Internal Medicine
- HSIN-YUN SUN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
680 participants
